Ticker
QLGNCompany Name
QUALIGEN THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Issuance (Repayment) of Debt Securities | Net Cash Flow - Dividends & Other Cash Distributions | Shareholder Yield |
---|---|---|---|---|---|
6/30/2025 | $ 2.98M | $ 3.32M | $ 2.86M | $ 0 | -207.22% |
3/31/2025 | $ 5.02M | $ 3.47M | $ 1.25M | $ 0 | -94.01% |
12/31/2024 | $ 5.58M | $ 3.47M | $ 975.98K | $ 0 | -79.64% |
9/30/2024 | $ 2.99M | $ 3.47M | $ 1.36M | $ 0 | -161.69% |
6/30/2024 | $ 2.47M | $ 150K | $ 925K | $ 0 | -43.46% |
3/31/2024 | $ 1.59M | $ 0 | $ -75K | $ 0 | 4.71% |
12/31/2023 | $ 2.41M | $ 0 | $ -550K | $ 0 | 22.86% |
9/30/2023 | $ 3.81M | $ -505 | $ 2.46M | $ 0 | -64.69% |
6/30/2023 | $ 5.31M | $ -505 | $ 2.9M | $ 0 | -54.73% |
3/31/2023 | $ 5.15M | $ -505 | $ 2.9M | $ 0 | -56.34% |
(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield
Shareholder Yield for QUALIGEN THERAPEUTICS INC is calculated as follows: (-1 * CF - Equity [ $ 23.99M ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ 428.29K ]) / Market Cap [ $ 80.48M ]
(=) Shareholder Yield [ -30.34% ]
Minimum
Jun 30, 2025
Maximum
Dec 31, 2023
Average
Median
filtered constituents | 3.48K |
---|---|
min | -33.38% |
max | 34.45% |
average | 0.59% |
median | 1.08% |
std | 11.11% |